|
- 积分
- 80
- 威望
- 80
- 包包
- 167
|
回复 蒲公英 的帖子5 `0 {0 o+ Q" f$ U, r F. U
$ |0 u9 Y1 |' h5 n! A: |( p9 u3 Y参考文献：% g! F6 H5 B0 m6 p$ Q7 b$ P
1 Krampera M, Glennie S, Dyaon J，et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigenspecific T cells to their cognate peptide. Blood, 2003;101:3722-3729
+ ]0 Q2 U9 w* B% B. { r2 Potian JA, Aviv H, Ponzio NM, et al. Vetolike activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J Immunol, 2003;171:3426-34349 w( t1 n% @) r; z. s( J' {8 z3 L4 a
3 Klyushnenkova E, Mosca JD, Zernetkina V, et al. T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J Biomed Sci, 2005;12:47-57
' r6 J! S2 e" T) @/ ]) g- ]# m% S, s
2 C4 f* @' |9 w4 v$ ?: u% j4 DiNicola M, CarloStella C, Magni M, et al. Human bone marrow stromal cells suppress Tlymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood, 2002;99:3838-3843
9 {4 I- v+ ~# r" e6 _# _; t' S6 ?" S2 o+ b
5 Rasmusson I, Ringden O, Sundberg B, et al. Mesenchymal stem cells inhibit lymphocyte proliferation by mitrogens and alloantigens by different mechanisms. Exp Cell Res, 2005; 305：33-41
% |; v* f( { q+ M0 E: R, X- y4 H, o5 H1 E$ A/ A
6 Sun S，Guo Z，Xiao X，et al. Isolation of mouse marrow mesenchymal progenitors by a novel and reliable method. Stem Cell, 2003;21:527-535# X& P- t% i, b% e
; i) C. c+ s% R, v2 b" P: A
7 Maccario R, Podesta M, Moretta A, et al. Interaction of human mesenchymal stem cells with cells involved in alloantigenspecific immune response favors the differentiation of CD4 Tcell subsets expressing a regulatory/suppressive phenotype. Haematologica, 2005;90:516-525: K9 i! @# U, Q+ O, S
; U+ t, w0 I: H5 }+ e8 Djouad F, Plence P, Bony C, et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood, 2003;102: 3837-38446 }/ V+ |& |0 m0 J. c3 ?& w
8 x# J* R% T9 B6 b7 j
9 Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell response. Blood, 2005; 105:1815-1822
$ U' c% ?7 I5 Q8 A3 o3 Q
\: W# c3 U% C. ]: ^10 Beyth S, Borovsk Z, Mevorach D，et al. Human mesenchymal stem cells alter antigen presenting cell maturation and induce Tcell unresponsiveness. Blood, 2005; 105:2214-2219
! z9 q* K8 F6 ^( i
1 [; \/ P! N6 r9 T. F/ o$ P11 Jiang XX, Zhang Y, Liu B, et al. Human mesenchymal stem cells inhibit differentiation and function of monocytederived dentritic cells. Blood, 2005; 105; 4120-4126
# L! B/ _7 ]1 ]7 J D( a* f
( ^+ M- n. d$ T12 Nauta AJ, Kruisselbrink AB, Lurvink E, et al. Mesenchymal stem cells inhibit generation and function of both CD34 derived and monocytederived dendritic cells. J Immunol, 2006; 177: 2080-2087% q# c) d2 ~ }
+ B: @6 H5 q, ~2 \. [2 a% V2 V! r
13 Rasmusson I, Ringden O, Sundberg B, et al. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation, 2003; 76 :1208-12130 B7 R; }6 |$ X: j4 h
( P0 n+ N. j# i! ?0 Y q14 Angoulvant D, Clerc A, Benchalal S, et al. Human mesenchymal stem cells suppress induction of cytotoxic response to alloantigens. Biorheology, 2004; 41:469-476: k1 R. w6 y' M( j6 x/ d
) G1 _" N, M' q. l9 V9 p" b3 [. a" R
15 Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol, 2002; 30: 42-48
/ u" v" V- O+ F2 v* z/ l! J3 z( ?# r) L3 b$ @
16 Guo Z, Li H, Li X, et al. In vitro characteristics and in vivo immunosuppressive activity of compact bonederived murine mesenchymal progenitor cells. Stem Cells,2006; 24: 992-1000
& n, r: J: q3 w7 T2 n) v4 W
* O, g7 b0 W+ @17 Zappia E, Casazza S, Pedemonte E, et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T cell anergy. Blood, 2005; 106: 1755-1761
/ O; h: S1 c$ V! {) N( n8 o9 M5 w. g. v" o* a8 g: [) m; d
18 Lazarus HM, Haynesworth SE, Gerson SL, et al. Ex vivo expansion and subsequent infusion of human bone marrowderived stromal progenitor cells (mesenchymal stem cells): implication for therapeutic use. Bone Marrow Transplant, 1995; 16: 557-564
7 D8 m( _# S! w- ?" P4 M( { h2 z5 D. ^8 v7 e# Z( J
19 Lazarus HM, Koc ON, Devine SM, et al. Cotransplantation of HLAidentical sibling cultureexpanded mesenchymal stem cells and hematopioetic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant, 2005; 11:389-398
; h+ K+ j$ \1 c! ?
# z. O9 s a! l5 D9 Y. @- J20 Lee ST, Jang JH, Cheong JW, et al. Treatment of highrisk acute myelogenous leukemia by myeloablative chemoradiotherapy followed by coinfusion of T celldepleted haematopioetic stem cells and cultureexpanded marrow mesenchymal stem cells from a related donor with one fully mismatched human leucocyte antigen haplotype. Br J Haematol, 2002; 118:1128-11316 h& f" S5 H* K
7 a G- g' K! B: ~8 }% J* Y$ [) }8 v/ Z
21 LeBlanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graftversushost disease with third party haploidentical mesenchymal stem cells. Lancet, 2004; 363(9419):1439-1411
- T7 F9 ?/ ~3 z; F) i2 ^* e& A% }0 e |
-
总评分: 威望 + 2
包包 + 10
查看全部评分
|
发表于 2013-3-25 12:36
大家帮忙看看，给点意见和建议哈~
我也只是列举了一小部分
发表于 2013-3-31 09:05
